NEWS

2022620

Media Interview with Keiichi Fukuda was published in "Features", Keio University School of Medicine.

2022614

Congress Takehiko Kaneko, CMO at Heartseed, is speaking at this year's webinar by American Physiological Society.

2022614

Congress Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's iPSC Manufacturing Summit in July 26-28.

202267

Media Interview with Takehiko Kaneko, CMO and Head of R&D at Heartseed, was published in RegMedNet.

2022128

Media Heartseed was featured by NHK World's CATCH JAPAN.

2022111

Media An interview with Kikuo Yasui, COO was published in Venture Valuation.

20211124

Media Featured Story on Heartseed was listed on Science Japan by Japan Science and Technology Agency (JST).
"Developing a next-generation therapy for severe heart failure using iPS cells"

2021810

PR Heartseed named "Ministry of Education, Culture, Sports, Science and Technology (MEXT) Award" at Academic Startups 2021

202172

Other LAPiS Study, a Phase I/II Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With HF is posted on ClinicalTrials.gov

2021622

Congress Kikuo Yasui, COO speaks at the International Society for Stem Cell Research (ISSCR) 2021, "Driving Change in Regenerative Medicine Through Global Partnerships: Organized by Novo Nordisk Stem Cell R&D"

1 2 3 4 5 6 7 8